Literature DB >> 20810194

Synthesis of some p-toluenesulfonyl-hydrazinothiazoles and hydrazino-bis-thiazoles and their anticancer activity.

Valentin Zaharia1, Adriana Ignat, Nicolae Palibroda, Bathélémy Ngameni, Victor Kuete, Charles N Fokunang, Marlyse L Moungang, Bonaventure T Ngadjui.   

Abstract

A series of novel p-toluenesulfonyl-hydrazinothiazoles and hydrazino-bis-thiazoles derivatives (2a-f, 3a-f and 5-8) were synthesized by initial condensation of p-toluenesulfonylthiosemicarbazide 1 with a series of α-halogenocarbonyls in acetone or dimethylformamide (DMF)/acetone, mixture. All our synthesized compounds were submitted for further acylation reaction in the presence of acetic anhydride. The structures of newly synthesized derivatives 2a-f, 3a-f and 5-8 were confirmed by IR, (1)H-NMR, EIMS spectral data and elemental analysis. Compounds 2a, 2c, 2d, 2e and 3a showed significant anticancer activities (IC(50)<10 μM) on both prostate DU-145 and hepatocarcinoma Hep-G2 cancer cell lines.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810194     DOI: 10.1016/j.ejmech.2010.08.017

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Ethyl 2-[(tert-but-oxy-carbon-yl)amino]-thia-zole-5-carboxyl-ate.

Authors:  Weisong Wang; Bohua Zhong; Weiguo Shi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-17

2.  The synthesis and antiproliferative activities of new arylidene-hydrazinyl-thiazole derivatives.

Authors:  Adriana Grozav; Luiza Ioana Găină; Valentina Pileczki; Ovidiu Crisan; Luminita Silaghi-Dumitrescu; Bruno Therrien; Valentin Zaharia; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2014-12-01       Impact factor: 5.923

3.  N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents.

Authors:  Ahmad Mohammadi-Farani; Alireza Foroumadi; Monireh Rezvani Kashani; Alireza Aliabadi
Journal:  Iran J Basic Med Sci       Date:  2014-07       Impact factor: 2.699

4.  In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes.

Authors:  Armelle T Mbaveng; Adriana Grozav Ignat; Bathélémy Ngameni; Valentin Zaharia; Bonaventure T Ngadjui; Victor Kuete
Journal:  BMC Pharmacol Toxicol       Date:  2016-01-19       Impact factor: 2.483

5.  Cytotoxicity and Antioxidant Potential of Novel 2-(2-((1H-indol-5yl)methylene)-hydrazinyl)-thiazole Derivatives.

Authors:  Adriana Grozav; Ioan-Dan Porumb; Luiza Ioana Găină; Lorena Filip; Daniela Hanganu
Journal:  Molecules       Date:  2017-02-09       Impact factor: 4.411

6.  New Thiazoline-Tetralin Derivatives and Biological Activity Evaluation.

Authors:  Gülhan Turan-Zitouni; Leyla Yurttaş; Aouatef Tabbi; Gülşen Akalın Çiftçi; Halide Edip Temel; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2018-01-10       Impact factor: 4.411

7.  Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.

Authors:  Manar G Salem; Dina M Abu El-Maaty; Yassmina I Mohey El-Deen; Basem H Elesawy; Ahmad El Askary; Asmaa Saleh; Essa M Saied; Mohammed El Behery
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

8.  Substituted 2-[(2-Oxo-2H-[1,2,4]triazino [2,3-c]quinazolin-6-yl)thio]acetamides with Thiazole and Thiadiazole Fragments: Synthesis, Physicochemical Properties, Cytotoxicity, and Anticancer Activity.

Authors:  Sergey I Kovalenko; Inna S Nosulenko; Alexey Yu Voskoboynik; Galina G Berest; Lyudmyla N Antypenko; Alexey N Antypenko; Andrey M Katsev
Journal:  Sci Pharm       Date:  2012-10-04

9.  Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cells.

Authors:  Victor Kuete; Louis P Sandjo; Armelle T Mbaveng; Jackson A Seukep; Bonaventure T Ngadjui; Thomas Efferth
Journal:  BMC Complement Altern Med       Date:  2015-09-04       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.